Gremlin-1 antagonist for the prevention and treatment of cancer | Patent Publication Number 20210253688
US 20210253688 A1Patent NumberUS 12162934 B2
Application Number17253660
Filled DateJun 18, 2019
Priority DateJun 18, 2019
Publication DateAug 19, 2021
Original AssigneeThe University Of Adelaide
Ucb
Oxford University Innovation Limited
Ucb
Oxford University Innovation Limited
Current AssigneeThe University Of Adelaide
Inventor/ApplicantsGareth Charles Glyndwr Davies
Simon Leedham
VASILIOS PANAGOPOULOS
Kimberley Clark
SIMON LEEDHAM
ANDREW ZANNETTINO
GARETH CHARLES GLYNDWR DAVIES
DUNCAN HEWETT
Duncan Hewett
KIMBERLEY CLARK
Vasilios Panagopoulos
Andrew Zannettino
Simon Leedham
VASILIOS PANAGOPOULOS
Kimberley Clark
SIMON LEEDHAM
ANDREW ZANNETTINO
GARETH CHARLES GLYNDWR DAVIES
DUNCAN HEWETT
Duncan Hewett
KIMBERLEY CLARK
Vasilios Panagopoulos
Andrew Zannettino
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.